Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Gibco™ Mouse IL-28A (IFN-lambda 2) Recombinant Protein, PeproTech®

Catalog No. 25033100UG
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
100 μg
20 μg
250 μg
5 μg
500 μg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
25033100UG 100 μg
250-33-1MG 1 mg
250-33-20UG 20 μg
25033250UG 250 μg
25033500UG 500 μg
250-33-5UG 5 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
This item is not returnable. View return policy
Catalog No. 25033100UG Supplier Gibco™ Supplier No. 25033100UG
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Recombinant Protein

Recombinant Murine IFN- lambda2 is a 19.8 kDa protein containing 175 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis

IL-28A belongs to the IFN lambda family, a novel family of cytokines within the IL-10 superfamily. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2), and IL-28B (IFN lambda 3), and are also known as the type III Interferons.The IFN lambdas signal through a heterodimeric receptor of which one subunit, IL-10R2, is shared with other members of the superfamily. The second subunit, IFN lambda R1 or IL-28R alpha, is unique to the IFN lambdas. Signaling occurs through the Jak/STAT pathway in a similar manner as the type I IFN (IFN alpha/beta) and activates many of the same genes despite low sequence homology between the cytokines and receptors in the two families. Both IFN families display antiviral activity through the induction of antiviral protein production in target cells and the upregulation of MHC class I expression. These proteins also exhibit antiproliferative and antitumor effects, making them a possible alternative to IFN alpha cancer therapies. Unlike the type I IFN, which are able to stimulate most cells, response to IFN lambda stimulation appears to be limited to dendritic and some tumor cells due to the limited expression of IFN lambda R1. Another notable difference is the ability of the IFN lambda stimulation to drive dendritic cells towards the production of CD4+CD25+FoxP3+ regulatory T cells, suggesting a possible immunoregulatory role
TRUSTED_SUSTAINABILITY

Specifications

Accession Number Q4VK74
For Use With (Application) Functional Assay
Formulation protein with no preservative
Gene ID (Entrez) 330496
Molecular Weight (g/mol) 19.8 kDa
Name Mouse IL-28 A (IFN-lambda 2)
Quantity 100 μg
Source E. coli
Regulatory Status RUO
Endotoxin Concentration <1 EU/ μg
Gene Alias cytokine Zcyto20; EG330496; Ifnl2; IFN-lambda2; IFN-lambda-2; Il28a; IL-28 A; ILN; interferon lambda 2; interferon lambda-2; interferon, lambda 2; interferon-lambda 2; interferon-lambda2; Interleukin; interleukin 28 A; interleukin 28 A (interferon, lambda 2); interleukin-28 A; ZCYTO20
Common Name IL-28 A
Gene Symbol IFNL2
Biological Activity Determined by its ability to activate STAT following receptor-ligand interaction.
Conjugate Unconjugated
Recombinant Recombinant
Sequence MDPVPRATRL PVEAKDCHIA QFKSLSPKEL QAFKKAKDAI EKRLLEKDMR CSSHLISRAW DLKQLQVQER PKALQAEVAL TLKVWENMTD SALATILGQP LHTLSHIHSQ LQTCTQLQAT AEPKPPSRRL SRWLHRLQEA QSKETPGCLE DSVTSNLFRL LTRDLKCVAS GDQCV
Content And Storage -20°C
Expression System E. coli
Form Lyophilized
Purity or Quality Grade ≥ 98% by SDS-PAGE gel and HPLC analyses.
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.